Suppliers / Optrix Laboratories

Optrix Laboratories

India Updated 9 July 2026

Optrix Laboratories is an API manufacturer based in India. It appears in 5 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $68K of exports covering 2 molecules to 2 destinations in 2022.

0
active US DMFs
0
valid CEPs
0
registered plants
5
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Eletriptan SFDA (Saudi Arabia) 1
Favipiravir SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 5 None

Scale

Year Revenue Exports Destinations
2022 Not reported $68K 2

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Optrix Laboratories

Does Optrix Laboratories hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Optrix Laboratories. It does have 5 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Optrix Laboratories make?
2 molecules are on record against Optrix Laboratories, including Eletriptan and Favipiravir. Each links through to that molecule's full manufacturer list.
Where does Optrix Laboratories file?
Filings are on record with CDSCO (India), 5 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Optrix Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts